Haematological emergencies managing hypercalcaemia in adults and children with haematological disorders.

Hdl Handle:
http://hdl.handle.net/10147/207427
Title:
Haematological emergencies managing hypercalcaemia in adults and children with haematological disorders.
Authors:
Sargent, Jeremy T S; Smith, Owen P
Affiliation:
Trinity College, and Department of Haematology & Oncology, Our Lady's Children's , Hospital, Crumlin, Dublin, Ireland.
Citation:
Br J Haematol. 2010 May;149(4):465-77. Epub 2010 Apr 4.
Journal:
British journal of haematology
Issue Date:
1-Feb-2012
URI:
http://hdl.handle.net/10147/207427
DOI:
10.1111/j.1365-2141.2010.08173.x
PubMed ID:
20377591
Abstract:
Hypercalcaemia is a common metabolic complication of malignant disease often requiring emergency intervention. Although it is more frequently associated with solid tumours, malignancy-associated hypercalcaemia (MAH) is seen in a significant number of patients with blood diseases. Its association with myeloma and adult T-cell leukaemia/lymphoma is well recognized but the incidence of hypercalcaemia in other haematological neoplasms, affecting adults and children, is less clearly defined. Haematologists need to be familiar with the clinical manifestations of, the differential diagnosis to be considered and the most effective management strategies that are currently available for MAH. The key components of management of MAH include aggressive rehydration, specific therapy to inhibit bone resorption and, crucially, treatment of the underlying malignancy. Bisphosphonates have revolutionized the management of MAH over the last 20 years, however the elucidation of molecular pathways implicated in MAH is facilitating the development of more targeted approaches to treatment.
Language:
eng
MeSH:
Adult; Bone Density Conservation Agents/therapeutic use; Child; Diphosphonates/therapeutic use; Fluid Therapy/methods; Hematologic Neoplasms/*complications; Humans; Hypercalcemia/diagnosis/*etiology/*therapy
ISSN:
1365-2141 (Electronic); 0007-1048 (Linking)

Full metadata record

DC FieldValue Language
dc.contributor.authorSargent, Jeremy T Sen_GB
dc.contributor.authorSmith, Owen Pen_GB
dc.date.accessioned2012-02-01T10:24:44Z-
dc.date.available2012-02-01T10:24:44Z-
dc.date.issued2012-02-01T10:24:44Z-
dc.identifier.citationBr J Haematol. 2010 May;149(4):465-77. Epub 2010 Apr 4.en_GB
dc.identifier.issn1365-2141 (Electronic)en_GB
dc.identifier.issn0007-1048 (Linking)en_GB
dc.identifier.pmid20377591en_GB
dc.identifier.doi10.1111/j.1365-2141.2010.08173.xen_GB
dc.identifier.urihttp://hdl.handle.net/10147/207427-
dc.description.abstractHypercalcaemia is a common metabolic complication of malignant disease often requiring emergency intervention. Although it is more frequently associated with solid tumours, malignancy-associated hypercalcaemia (MAH) is seen in a significant number of patients with blood diseases. Its association with myeloma and adult T-cell leukaemia/lymphoma is well recognized but the incidence of hypercalcaemia in other haematological neoplasms, affecting adults and children, is less clearly defined. Haematologists need to be familiar with the clinical manifestations of, the differential diagnosis to be considered and the most effective management strategies that are currently available for MAH. The key components of management of MAH include aggressive rehydration, specific therapy to inhibit bone resorption and, crucially, treatment of the underlying malignancy. Bisphosphonates have revolutionized the management of MAH over the last 20 years, however the elucidation of molecular pathways implicated in MAH is facilitating the development of more targeted approaches to treatment.en_GB
dc.language.isoengen_GB
dc.subject.meshAdulten_GB
dc.subject.meshBone Density Conservation Agents/therapeutic useen_GB
dc.subject.meshChilden_GB
dc.subject.meshDiphosphonates/therapeutic useen_GB
dc.subject.meshFluid Therapy/methodsen_GB
dc.subject.meshHematologic Neoplasms/*complicationsen_GB
dc.subject.meshHumansen_GB
dc.subject.meshHypercalcemia/diagnosis/*etiology/*therapyen_GB
dc.titleHaematological emergencies managing hypercalcaemia in adults and children with haematological disorders.en_GB
dc.contributor.departmentTrinity College, and Department of Haematology & Oncology, Our Lady's Children's , Hospital, Crumlin, Dublin, Ireland.en_GB
dc.identifier.journalBritish journal of haematologyen_GB
dc.description.provinceLeinster-

Related articles on PubMed

All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.